Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection.

Petta S, Macaluso FS, Cammà C, Marco VD, Cabibi D, Craxì A.

Liver Int. 2012 Oct;32(9):1443-50. doi: 10.1111/j.1478-3231.2012.02842.x. Epub 2012 Jul 5.

PMID:
22764879
2.

Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.

Petta S, Cammà C, Cabibi D, Di Marco V, Craxì A.

Aliment Pharmacol Ther. 2011 Oct;34(7):757-66. doi: 10.1111/j.1365-2036.2011.04788.x. Epub 2011 Jul 25.

3.

Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.

Kara B, Gunesacar R, Doran F, Kara IO, Akkiz H.

Adv Ther. 2007 Sep-Oct;24(5):972-82.

PMID:
18029322
4.

High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.

Petta S, Handberg A, Marchesini G, Cammà C, Di Marco V, Cabibi D, Macaluso FS, Craxì A.

J Viral Hepat. 2013 Mar;20(3):174-82. doi: 10.1111/j.1365-2893.2012.01641.x. Epub 2012 Jul 9.

PMID:
23383656
5.

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.

Petta S, Cammà C, Di Marco V, Alessi N, Barbaria F, Cabibi D, Caldarella R, Ciminnisi S, Licata A, Massenti MF, Mazzola A, Tarantino G, Marchesini G, Craxì A.

Hepatology. 2008 Jul;48(1):28-37. doi: 10.1002/hep.22316.

PMID:
18506842
6.

Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.

Hsu CS, Liu CH, Liu CJ, Hsu SJ, Chen CL, Hwang JJ, Lai MY, Chen PJ, Chen DS, Kao JH.

J Gastroenterol Hepatol. 2010 May;25(5):970-7. doi: 10.1111/j.1440-1746.2009.06186.x.

PMID:
20546452
7.

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.

Zografos TA, Liaskos C, Rigopoulou EI, Togousidis E, Makaritsis K, Germenis A, Dalekos GN.

Am J Gastroenterol. 2008 Mar;103(3):605-14. doi: 10.1111/j.1572-0241.2007.01729.x. Epub 2008 Jan 8.

PMID:
18190648
8.

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.

Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P.

Gastroenterology. 2008 Feb;134(2):416-23. doi: 10.1053/j.gastro.2007.11.010. Epub 2007 Nov 12.

PMID:
18164296
9.

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G.

Hepatology. 2001 Jun;33(6):1358-64.

PMID:
11391523
10.

Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.

Rafi H, Kabbaj N, Salihoun M, Amrani L, Acharki M, Guedira M, Nya M, Amrani N.

Arab J Gastroenterol. 2011 Sep;12(3):136-8. doi: 10.1016/j.ajg.2011.07.003. Epub 2011 Sep 15.

PMID:
22055591
11.

Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?

Pellicano R, Puglisi G, Ciancio A, Balzola F, Saracco G, Ciccone G, Baldi I, Abate ML, Smedile A, Rizzetto M.

J Med Virol. 2008 Apr;80(4):628-31. doi: 10.1002/jmv.21123.

PMID:
18297716
12.
13.

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.

Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J.

Hepatology. 2006 Dec;44(6):1648-55.

PMID:
17133473
14.

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

Hézode C, Zafrani ES, Roudot-Thoraval F, Costentin C, Hessami A, Bouvier-Alias M, Medkour F, Pawlostky JM, Lotersztajn S, Mallat A.

Gastroenterology. 2008 Feb;134(2):432-9. doi: 10.1053/j.gastro.2007.11.039. Epub 2007 Nov 28.

PMID:
18242211
15.

Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.

Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R.

Hepatogastroenterology. 1999 Jul-Aug;46(28):2422-5.

PMID:
10522010
16.

Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C.

Romero-Gómez M, Castellano-Megias VM, Grande L, Irles JA, Cruz M, Nogales MC, Alcón JC, Robles A.

Am J Gastroenterol. 2003 May;98(5):1135-41.

PMID:
12809839
17.

Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey.

Aksu HS, Kurtaran B, Onlen Y, Namiduru M, Inkaya AC, Kandemir O, Doran F, Evirgen O, Alpay Y, Tekin SK, Kurekci Y, Unlu B, Midikli D, Taşova Y, Ozdener F, Erdogan S.

Eur J Gastroenterol Hepatol. 2012 Dec;24(12):1393-9. doi: 10.1097/MEG.0b013e3283585863.

PMID:
23114743
18.

Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.

Maylin S, Laouénan C, Martinot-Peignoux M, Panhard X, Lapalus M, Nicolas-Chanoine MH, Bedossa P, Asselah T, Marcellin P.

J Clin Virol. 2012 Jan;53(1):43-7. doi: 10.1016/j.jcv.2011.09.029. Epub 2011 Nov 17.

PMID:
22099210
19.

Liver steatosis is an independent risk factor for treatment failure in patients with chronic hepatitis C.

Thomopoulos KC, Theocharis GJ, Tsamantas AC, Siagris D, Dimitropoulou D, Gogos CA, Labropoulou-Karatza C.

Eur J Gastroenterol Hepatol. 2005 Feb;17(2):149-53.

PMID:
15674091
20.

Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.

Vădan R, Gheorghe L, Becheanu G, Iacob R, Iacob S, Gheorghe C.

Rom J Gastroenterol. 2003 Sep;12(3):183-7.

PMID:
14502317

Supplemental Content

Support Center